Do neuronal autoantibodies cause psychosis? a neuroimmunological perspective

Biological Psychiatry

Volumn 75, Issue 4, 2014, Pages 269-275

  Coutinho, Ester ^a   Harrison, Paul ^a   Vincent, Angela ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antibody mediated disease; autoimmune encephalitis; psychosis; schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; AMPA RECEPTOR; ANTICONVULSIVE AGENT; AUTOANTIBODY; GLYCINE RECEPTOR; MEMBRANE ANTIGEN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBODY BLOOD LEVEL; ANTIBODY MEDIATED REJECTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CREUTZFELDT JAKOB DISEASE; DISEASE CLASSIFICATION; ENCEPHALOMYELITIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MENTAL DISEASE; MENTAL PATIENT; MOTOR DYSFUNCTION; MYELOOPTIC NEUROPATHY; MYOKYMIA; NEUROIMAGING; NEUROIMMUNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PATHOGENICITY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SERUM;

ANTIBODY-MEDIATED DISEASE; AUTOIMMUNE ENCEPHALITIS; PSYCHOSIS; SCHIZOPHRENIA;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; HUMANS; IMMUNOTHERAPY; NEURONS; PSYCHOTIC DISORDERS;

EID: 84892569288     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.07.040     Document Type: Review

References (62)

1. J. Keesey, and J. Aarli Something in the blood? A history of the autoimmune hypothesis regarding myasthenia gravis J Hist Neurosci 16 2007 395 412
2. W.L. Nastuk, A.J. Strauss, and K.E. Osserman Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis Am J Med 26 1959 394 409
3. J. Patrick, and J. Lindstrom Autoimmune response to acetylcholine receptor Science 180 1973 871 872
4. A.N. Bender, S.P. Ringel, W.K. Engel, M.P. Daniels, and Z. Vogel Myasthenia gravis: A serum factor blocking acetylcholine receptors of the human neuromuscular junction Lancet 1 1975 607 609
5. A. Roberts, S. Perera, B. Lang, A. Vincent, and J. Newsom-Davis Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line Nature 317 1985 737 739
6. P. Shillito, P.C. Molenaar, A. Vincent, K. Leys, W. Zheng, and R.J. van den Berg et al. Acquired neuromyotonia: Evidence for autoantibodies directed against K+ channels of peripheral nerves Ann Neurol 38 1995 714 722
7. L.L. Muldoon, J.I. Alvarez, D.J. Begley, R.J. Boado, G.J. Del Zoppo, and N.D. Doolittle et al. Immunologic privilege in the central nervous system and the blood-brain barrier J Cereb Blood Flow Metab 33 2013 13 21
8. F. Graus, A. Saiz, and J. Dalmau Antibodies and neuronal autoimmune disorders of the CNS J Neurol 257 2010 509 517
9. S.W. Rogers, P.I. Andrews, L.C. Gahring, T. Whisenand, K. Cauley, and B. Crain et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis Science 265 1994 648 651
10. R. Watson, Y. Jiang, I. Bermudez, L. Houlihan, L. Clover, and K. McKnight et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis Neurology 63 2004 43 50
11. H. Wiendl, C.G. Bien, P. Bernasconi, B. Fleckenstein, C.E. Elger, and J. Dichgans et al. GluR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis Neurology 57 2001 1511 1514
12. C. Buckley, J. Oger, L. Clover, E. Tuzun, K. Carpenter, and M. Jackson et al. Potassium channel antibodies in two patients with reversible limbic encephalitis Ann Neurol 50 2001 73 78
13. A. Vincent, C.G. Bien, S.R. Irani, and P. Waters Autoantibodies associated with diseases of the CNS: New developments and future challenges Lancet Neurol 10 2011 759 772
14. N.R. Rose, and C. Bona Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today 14 1993 426 430
15. E. Lancaster, M. Lai, X. Peng, E. Hughes, R. Constantinescu, and J. Raizer et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: Case series and characterisation of the antigen Lancet Neurol 9 2010 67 76
16. E. Lancaster, E. Martinez-Hernandez, and J. Dalmau Encephalitis and antibodies to synaptic and neuronal cell surface proteins Neurology 77 2011 179 189
17. S.R. Irani, A.W. Michell, B. Lang, P. Pettingill, P. Waters, and M.R. Johnson et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis Ann Neurol 69 2011 892 900
18. T. Brenner, G.J. Sills, Y. Hart, S. Howell, P. Waters, and M.J. Brodie et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy Epilepsia 54 2013 1028 1035
19. M.S. Zandi, S.R. Irani, B. Lang, P. Waters, P.B. Jones, and P. McKenna et al. Disease-relevant autoantibodies in first episode schizophrenia J Neurol 258 2011 686 688
20. J. Steiner, M. Walter, W. Glanz, Z. Sarnyai, H.G. Bernstein, and S. Vielhaber et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis JAMA Psychiatry 70 2013 271 278
21. I. Rubio-Agusti, J. Dalmau, T. Sevilla, M. Burgal, E. Beltran, and L. Bataller Isolated hemidystonia associated with NMDA receptor antibodies Mov Disord 26 2011 351 352
22. M.I. Leite, E. Coutinho, M. Lana-Peixoto, S. Apostolos, P. Waters, and D. Sato et al. Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients Neurology 78 2012 1601 1607
23. M.C. Kruer, T.K. Koch, D.N. Bourdette, D. Chabas, E. Waubant, and S. Mueller et al. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica Neurology 74 2010 1473 1475
24. M. Kurian, P.H. Lalive, J.O. Dalmau, and J. Horvath Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis Arch Neurol 67 2010 118 121
25. G. Mackay, K. Ahmad, J. Stone, C. Sudlow, D. Summers, and R. Knight et al. NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease J Neurol 259 2012 1979 1981
26. K. Fujita, T. Yuasa, Y. Takahashi, K. Tanaka, W. Sako, and H. Koizumi et al. Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients J Neuroimmunol 251 2012 90 93
27. A. Vincent, C. Buckley, J.M. Schott, I. Baker, B.K. Dewar, and N. Detert et al. Potassium channel antibody-associated encephalopathy: A potentially immunotherapy-responsive form of limbic encephalitis Brain 127 2004 701 712
28. R.W. Paterson, M.S. Zandi, R. Armstrong, A. Vincent, and J.M. Schott Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: Experience from a tertiary referral centre [published online ahead of print June 11] J Neurol Neurosurg Psychiatry. 2013
29. A. Vincent, L. Clover, C. Buckley, J. Grimley Evans, P.M. Rothwell, and U.K.M.G. Survey Evidence of underdiagnosis of myasthenia gravis in older people J Neurol Neurosurg Psychiatry 74 2003 1105 1108
30. E.H. Moscato, A. Jain, X. Peng, E.G. Hughes, J. Dalmau, and R.J. Balice-Gordon Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: Insights from molecular, cellular and synaptic studies Eur J Neurosci 32 2010 298 309
31. E.G. Hughes, X. Peng, A.J. Gleichman, M. Lai, L. Zhou, and R. Tsou et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis J Neurosci 30 2010 5866 5875
32. M. Lai, E.G. Hughes, X. Peng, L. Zhou, A.J. Gleichman, and H. Shu et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location Ann Neurol 65 2009 424 434
33. C.G. Bien, A. Vincent, M.H. Barnett, A.J. Becker, I. Blumcke, and F. Graus et al. Immunopathology of autoantibody-associated encephalitides: Clues for pathogenesis Brain 135 2012 1622 1638
34. S.R. Irani, S. Alexander, P. Waters, K.A. Kleopa, P. Pettingill, and L. Zuliani et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia Brain 133 2010 2734 2748
35. M. Hutchinson, P. Waters, J. McHugh, G. Gorman, S. O'Riordan, and S. Connolly et al. Progressive encephalomyelitis, rigidity, and myoclonus: A novel glycine receptor antibody Neurology 71 2008 1291 1292
36. A. McKeon, E. Martinez-Hernandez, E. Lancaster, J.Y. Matsumoto, R.J. Harvey, and K.M. McEvoy et al. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype JAMA Neurol 70 2013 44 50
37. A. Adell, L. Jimenez-Sanchez, X. Lopez-Gil, and T. Romon Is the acute NMDA receptor hypofunction a valid model of schizophrenia? Schizophr Bull 38 2012 9 14
38. D. Inta, H. Monyer, R. Sprengel, A. Meyer-Lindenberg, and P. Gass Mice with genetically altered glutamate receptors as models of schizophrenia: A comprehensive review Neurosci Biobehav Rev 34 2010 285 294
39. C. Nobile, R. Michelucci, S. Andreazza, E. Pasini, S.C. Tosatto, and P. Striano LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy Hum Mutat 30 2009 530 536
40. K.A. Strauss, E.G. Puffenberger, M.J. Huentelman, S. Gottlieb, S.E. Dobrin, and J.M. Parod et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2 N Engl J Med 354 2006 1370 1377
41. E. Stogmann, E. Reinthaler, S. Eltawil, M.A. El Etribi, M. Hemeda, and N. El Nahhas et al. Autosomal recessive cortical myoclonic tremor and epilepsy: Association with a mutation in the potassium channel associated gene CNTN2 Brain 136 2013 1155 1160
42. O. Penagarikano, and D.H. Geschwind What does CNTNAP2 reveal about autism spectrum disorder? Trends Mol Med 18 2012 156 163
43. J.I. Friedman, T. Vrijenhoek, S. Markx, I.M. Janssen, W.A. van der Vliet, and B.H. Faas et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy Mol Psychiatry 13 2008 261 266
44. M. Manto, J. Dalmau, A. Didelot, V. Rogemond, and J. Honnorat In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: Further evidence of synaptic glutamatergic dysfunction Orphanet J Rare Dis 5 2010 31
45. M. Manto, J. Dalmau, A. Didelot, V. Rogemond, and J. Honnorat Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies J Neurol 258 2011 27 33
46. M. Coesmans, P.A. Smitt, D.J. Linden, R. Shigemoto, T. Hirano, and Y. Yamakawa et al. Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies Ann Neurol 53 2003 325 336
47. A. McCarthy, J. Dineen, P. McKenna, M. Keogan, J. Sheehan, and T. Lynch et al. Anti-NMDA receptor encephalitis with associated catatonia during pregnancy J Neurol 259 2012 2632 2635
48. M.A. Kumar, A. Jain, V.E. Dechant, T. Saito, T. Rafael, and H. Aizawa et al. Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy Arch Neurol 67 2010 884 887
49. J. Magley, D. Towner, V. Tache, and M.L. Apperson Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis Obstet Gynecol 120 2012 480 483
50. M.J. Titulaer, L. McCracken, I. Gabilondo, T. Armangue, C. Glaser, and T. Iizuka et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study Lancet Neurology 12 2013 157 165
51. M.J. Thieben, V.A. Lennon, B.F. Boeve, A.J. Aksamit, M. Keegan, and S. Vernino Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody Neurology 62 2004 1177 1182
52. S.R. Irani, K. Bera, P. Waters, L. Zuliani, S. Maxwell, and M.S. Zandi et al. N-methyl-D-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes Brain 133 2010 1655 1667
53. R.D. Strous, and Y. Shoenfeld Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive model updated and revisited J Autoimmun 27 2006 71 80
54. A.L. Jones, B.J. Mowry, M.P. Pender, and J.M. Greer Immune dysregulation and self-reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol 83 2005 9 17
55. M. Rothermundt, V. Arolt, and T.A. Bayer Review of immunological and immunopathological findings in schizophrenia Brain Behav Immun 15 2001 319 339
56. W.W. Eaton, M. Byrne, H. Ewald, O. Mors, C.Y. Chen, and E. Agerbo et al. Association of schizophrenia and autoimmune diseases: Linkage of Danish national registers Am J Psychiatry 163 2006 521 528
57. M.E. Benros, P.R. Nielsen, M. Nordentoft, W.W. Eaton, S.O. Dalton, and P.B. Mortensen Autoimmune diseases and severe infections as risk factors for schizophrenia: A 30-year population-based register study Am J Psychiatry 168 2011 1303 1310
58. E.L. Messias, C.Y. Chen, and W.W. Eaton Epidemiology of schizophrenia: Review of findings and myths Psychiatr Clin North Am 30 2007 323 338
59. M. Fritzsche Geographical and seasonal correlation of multiple sclerosis to sporadic schizophrenia Int J Health Geogr 1 2002 5
60. H. Stefansson, R.A. Ophoff, S. Steinberg, O.A. Andreassen, S. Cichon, and D. Rujescu et al. Common variants conferring risk of schizophrenia Nature 460 2009 744 747
61. P. Jia, L. Wang, H.Y. Meltzer, and Z. Zhao Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data Schizophr Res 122 2010 38 42
62. K. Tsutsui, T. Kanbayashi, K. Tanaka, S. Boku, W. Ito, and J. Tokunaga et al. Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features BMC Psychiatry 12 2012 37